Abstract
Infection by COVID-19, being a respiratory disease caused by SARS-CoV-2, can predispose to arterial and venous thrombotic disease, in response to excessive inflammation, platelet activation, endothelial dysfunction, and venous stasis. During the COVID-19 pandemic period, the technological and resource availability for the care of these patients with thrombotic disease is critical, marking a factor of morbidity and poor prognosis in these cases. We describe a case of priapism in a patient with COVID-19, during the course of systemic inflammatory response syndrome and respiratory distress syndrome with a procoagulant state, seeking to relate the pathophysiological factors of ischemic priapism in patients with infection with SARS-Cov-2
References
1.
Zhu
N
, Zhang
D
, Wang
W
, Li
X
, Yang
B
, Song
J
, A novel coronavirus from patients with pneumonia in China, 2019
. N Engl J Med
. 2020 Feb 20
;382
(8
):727
–33
.2.
Bikdeli
B
, Madhavan
MV
, Jimenez
D
, Chuich
T
, Dreyfus
I
, Driggin
E
, COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up
. J Am Coll Cardiol
. 2020 Jun
;75
(23
):2950
–73
.3.
Cui
S
, Chen
S
, Li
X
, Liu
S
, Wang
F
. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia
. J Thromb Haemost
. 2020 Jun
;18
(18
):1421
–4
. .4.
Klok
F
, Kruip
M
, van der Meer
N
, Arbous
M
, Gommers
D
, Kant
K
, Incidence of thrombotic complications in critically ill ICU patients with COVID-19
. Thromb Res
. 2020 Jul
;191
(191
):145
–7
. .5.
Lamamri
M
, Chebbi
A
, Mamane
J
, Abbad
S
, Munuzzolini
M
, Sarfati
F
, Priapism in a patient with coronavirus disease 2019 (COVID-19): a case report
. Am J Emerg Med
. 2021 Jan
;39
:251.e5
–e7
.6.
Muneer
A
, Cellek
S
, Dogan
A
, Kell
PD
, Ralph
DJ
, Minhas
S
. Investigation of cavernosal smooth muscle dysfunction in low flow priapism using an in vitro model
. Int J Impot Res
. 2005 Jan
;17
(1
):10
–8
. .7.
Salonia
A
, Eardley
I
, Giuliano
F
, Hatzichristou
D
, Moncada
I
, Vardi
Y
, European association of urology guidelines on priapism
. Eur Urol
. 2014 Feb
;65
(65
):480
–9
. .8.
Lippi
G
, Favaloro
EJ
. D-dimer is associated with severity of coronavirus disease 2019: a pooled analysis
. Thromb Haemost
. 2020 May
;120
(120
):876
–8
. .9.
Lillicrap
D
. Disseminated intravascular coagulation in patients with 2019-nCoV pneumonia
. J Thromb Haemost
. 2020 Apr
;18
(18
):786
–7
. .10.
Chen
J
, Wang
X
, Zhang
S
, Liu
B
, Wu
X
, Wang
Y
, Findings of acute pulmonary embolism in COVID-19 patients
. Lancet Infect Dis
. 2020
.11.
Muneer
A
, Ralph
D
. Guideline of guidelines: priapism
. BJU Int
. 2017 Feb
;119
(2
):204
–8
. .12.
Corten
BJGA
, Aarts
F
, Harms
AS
, Vogelaar
J
. Postoperative drug-induced priapism
. BMJ Case Rep
. 2017 May 31
;2017
:bcr2016218060
.13.
Senthilkumaran
S
, Shah
S
, Ganapathysubramanian
, Balamurgan
N
, Thirumalaikolundusubramanian
P
. Propofol and priapism.Indian J Pharmacol
. 2010 Aug
;42
(4
):238
–9
.14.
Downie
I
, Liederman
Z
, Thiyagarajah
K
, Selby
R
, Lin
Y
. Pseudo heparin resistance caused by elevated factor VIII in a critically ill patient
. Can J Anaesth
. 2019 Aug
;66
(66
):995
–6
. .15.
Tang
N
, Li
D
, Wang
X
, Sun
Z
. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia
. J Thromb Haemost
. 2020 Apr
;18
(18
):844
–7
. .© 2021 S. Karger AG, Basel
2021
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
